Integrase Inhibitors: Clinical Considerations | Jonathan Schapiro, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Epidemiology of Hepatitis B in Central and Eastern Europe | Adrian Streinu Cercel, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

HCV - The Virus - Geoffrey Dusheiko, MD, MB, BCh

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Acute Hepatitis C - Christoph Boesecke, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Non Hepatic Complications - Kenneth Sherman, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Chronic HepatitiRockstrohs and HIV: Implications For Care - Jürgen Rockstroh, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Treatment of HCV in HIV - Mark Sulkowski, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

ESLD a Guide for HIV Physicians - Marion Peters, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

What's new in HCV/HIV coinfection therapy - Mark Sulkowski, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Will DAA drug-drug interactions matter in the future - David Back, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Viral hepatitis and pregnancy - Eleni Nastouli

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Cost per cure-is it worth it? - Douglas Dieterich, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Towards more affordable HCV therapy - Andrew Hill, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Management of HCV: Pre and Post transplant - Kosh Agarwal, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

ESLD and its complications - Massimo Puoti, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Immunology and the pathophysiology of liver disease in coinfection - Raymond Chung, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

NASH, what is it, who gets it and what are the implication for the HIV patient - Emmanouil Tsochatzis, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

HBV - Current and Future Treatment paradigms - Patrick Kennedy, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Viral Hepatitis and Malignancy - David Pinato, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Delta Hepatitis-New approaches to therapy - Vincent Soriano, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

26_Dieterich

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Recreational drug use in the HIV population - David Stuart

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Debate: HIV is no special population anymore - Sanjay Bhagani, BSc, FRCP

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015